Coronary wall imaging in mice using osmium tetroxide and micro-computed tomography

被引:0
作者
Kozlowski, M. [1 ]
Donohue, D. [2 ]
Chen, M. [1 ]
Daniels, M. [3 ]
Connelly, P. [3 ]
Jeffries, K. [4 ]
Clevenger, R. [4 ]
Wen, H. [1 ]
Pai, V. M. [1 ]
机构
[1] NHLBI, Lab Imaging Phys Biochem & Biophys Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[2] NIH, MIF, Bethesda, MD 20892 USA
[3] NIH, NHLBI, Electron Microscopy Core, Bethesda, MD 20892 USA
[4] NIH, NHLBI, LAMS, Bethesda, MD 20892 USA
来源
MOLECULAR IMAGING III | 2011年 / 8089卷
关键词
Atherosclerosis; osmium tetroxide; microcomputed tomography; mouse; DISEASE;
D O I
10.1117/12.888991
中图分类号
O43 [光学];
学科分类号
070207 ; 0803 ;
摘要
Coronary artery disease (CAD) is a major cause of death in the United States and results from the accumulation of atherosclerotic plaques in the arteries of the heart. Plaques accumulate as the result of the retention of low-density lipoprotein (LDL) particles in the sub-endothelium of the arterial wall. In mouse aorta, these lesions form primarily at the branching sites or bifurcations. However, in the coronary system, data has shown that late-stage plaque formation occurs throughout the proximal segments of the arteries. In order to better understand plaque formation in the coronary arteries, we have developed an osmium tetroxide (OsO4) stained coronary wall imaging protocol performed using microcomputed tomography (microCT). OsO4 is a heavy metal contrast agent that readily binds to lipids. Our data in 3- to 25-week old C57BL6 wild-type mice shows that the coronary vessel walls are highlighted by the use of the contrast agent. We expect that this combination of OsO4 and microCT will allow us to investigate the coronary artery wall in atherogenesis models of mice to characterize plaque formation.
引用
收藏
页数:8
相关论文
共 10 条
  • [1] Ananda S, 2006, J ELECTRON MICROSC, V55, P151, DOI [10.1093/jmicro/dfl015, 10.1093/jmicro/df1015]
  • [2] Molecular, cellular and functional imaging of atherothrombosis
    Choudhury, RP
    Fuster, V
    Fayad, ZA
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) : 913 - 925
  • [3] FUSTER V, NATURE REV CARDIOLOG, V7, P327
  • [4] Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
    Hansson, GK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) : 1685 - 1695
  • [5] Atherosclerotic lesions in the common coronary arteries of ApoE knockout mice
    Hu, WC
    Polinsky, P
    Sadoun, E
    Rosenfeld, ME
    Schwartz, SM
    [J]. CARDIOVASCULAR PATHOLOGY, 2005, 14 (03) : 120 - 125
  • [6] Roger V L., CIRCULATION
  • [7] Molecular imaging in cardiovascular disease: targets and opportunities
    Shaw, Stanley Y.
    [J]. NATURE REVIEWS CARDIOLOGY, 2009, 6 (09) : 569 - 579
  • [8] Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences
    Viles-Gonzalez, JF
    Fuster, V
    Badimon, JJ
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (14) : 1197 - 1207
  • [9] Coronary artery spatial distribution of acute myocardial infarction occlusions
    Wang, JC
    Normand, SLT
    Mauri, L
    Kuntz, RE
    [J]. CIRCULATION, 2004, 110 (03) : 278 - 284
  • [10] Early changes in coronary artery wall structure detected by microcomputed tomography in experimental hypercholesterolemia
    Zhu, Xiang-Yang
    Bentley, Michael D.
    Chade, Alejandro R.
    Ritman, Erik L.
    Lerman, Amir
    Lerman, Lilach O.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (03): : H1997 - H2003